Dragos Georgescu is an expert in Oncology at Centre Henri Becquerel (France). Dragos Georgescu has authored 12 publications, the most recent in 2024, and is an investigator in 1 clinical trial. SLR score: 36 (community average: 125). How the SLR is computed.

LeadR Profile

Dragos Georgescu Centre Henri Becquerel France
36 ScienceLeadR Reputation 36
Network Map

Oncology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2014 - 2023

Source: PubMed

Centre Henri Becquerel

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 12

Citations

Citations: 105 1st author: 0 Last author: 2 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Extended autologous tracheal replacement by a novel pedicled thoraco-chondro-costal flap: a cadaveric proof of concept.
PMID 38400739 — thoracic surgery, pleura, cardiac surgical procedures, trachea
Eur J Cardiothorac Surg20241
Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma.
PMID 37924026 — neoplasms, hormones, therapeutics, artificial intelligence, mutation, endometrial neoplasms
BMC Cancer20235
[Psychological impact of the announcement of an abnormal cervical smear: How to improve patient experience and information? COLANX: a multicenter study in Seine-Maritime].
PMID 36804626 — genital diseases, female, quality of life, psychological distress, colposcopy, vaginal smears
Gynecol Obstet Fertil Senol20232
2022-RA-783-ESGO Clinical relevance of circulating<i>ESR1</i>mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma
OpenAlex W4312826022 — neoplasms, hormones, therapeutics, mutation, carcinoma
Endometrial cancer20220
Retrospective analysis of the safety of peripherally inserted catheters versus implanted port catheters during first-line treatment for patients with diffuse large B-cell lymphoma.
PMID 35285085 — hematology, infections, lymphoma, b-cell, lymphoma, large b-cell, diffuse, risk, cells, therapeutics, thrombosis, safety, b-lymphocytes, central venous catheters
Eur J Haematol202210

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 2 1

By status:

Unknown 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map